Anebulo Pharmaceuticals Ownership | Who Owns Anebulo Pharmaceuticals?


OverviewForecastFinancialsChart

Anebulo Pharmaceuticals Ownership Summary


Anebulo Pharmaceuticals is owned by 0.91% institutional investors, 40.54% insiders, and 58.55% retail investors. 22nw, lp is the largest institutional shareholder, holding 45.73% of ANEB shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 0.29% of its assets in Anebulo Pharmaceuticals shares.

ANEB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAnebulo Pharmaceuticals0.91%40.54%58.55%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
22nw, lp15.47M45.73%$38.67M
Nantahala capital management3.04M8.98%$7.59M
Mangrove partners2.53M7.47%$6.31M
Morgan stanley399.40K1.18%$998.51K
Vanguard group306.54K0.91%$766.35K
Geode capital management174.11K0.51%$435.57K
Ikarian capital157.72K0.47%$394.30K
Renaissance28.50K0.08%$71.25K
Northern trust24.39K0.07%$60.98K
Blackrock funding, inc. /de24.06K0.07%$60.15K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
22nw, lp15.47M18.22%$38.67M
Mangrove partners2.53M0.47%$6.31M
Nantahala capital management3.04M0.26%$7.59M
Rangeley capital20.00K0.04%$50.00K
Ikarian capital157.72K0.04%$394.30K
Xtx topco19.15K0.00%$47.88K
Boothbay fund management18.84K0.00%$47.09K
Morgan stanley399.40K0.00%$998.51K
Tower research capital llc (trc)1.75K0.00%$4.38K
Renaissance28.50K0.00%$71.25K

Top Buyers

HolderShares% AssetsChange
Vanguard group306.54K-90.59K
Renaissance28.50K0.00%28.50K
Northern trust24.39K-24.39K
Rangeley capital20.00K0.04%20.00K
Xtx topco19.15K0.00%19.15K

Top Sellers

HolderShares% AssetsChange
Lvw advisors---349.62K
King luther capital management---59.66K
Geode capital management174.11K--31.61K
Susquehanna group, llp---25.25K
Hrt financial lp---23.16K

New Positions

HolderShares% AssetsChangeValue
Renaissance28.50K0.00%28.50K$71.25K
Northern trust24.39K-24.39K$60.98K
Rangeley capital20.00K0.04%20.00K$50.00K
Xtx topco19.15K0.00%19.15K$47.88K
State street12.77K-12.77K$31.92K

Sold Out

HolderChange
Ameritas advisory services-10.00
Wells fargo & company/mn-62.00
Pnc financial services group-1.53K
Hrt financial lp-23.16K
Susquehanna group, llp-25.25K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20253-80.00%308,684-98.61%-0.01%3-57.14%--100.00%
Jun 30, 202518-22,591,946-0.12%822.72%8-11.11%3-25.00%
Mar 31, 20251820.00%22,618,2420.21%550.73%912.50%4-
Dec 31, 20241515.38%22,570,347207.34%8710.85%860.00%433.33%
Sep 30, 2024138.33%7,343,7340.49%283.57%525.00%350.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF121.00K0.29%-
Vanguard Total Stock Mkt Idx Inv118.41K0.29%-2.59K
Fidelity Extended Market Index96.94K0.24%471.00
Vanguard Institutional Extnd Mkt Idx Tr92.03K0.22%-2.92K
Fidelity Total Market Index48.06K0.12%-102.00
Fidelity Series Total Market Index39.07K0.10%-413.00
Spartan Extended Market Index Pool F35.43K0.09%23.55K
iShares Micro-Cap ETF20.17K0.05%-
Spartan Total Market Index Pool G19.77K0.05%17.48K
Spartan Extended Market Index Pool E10.74K0.03%6.32K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 23, 2024English Aron R. Buy$10.00M
Dec 17, 2021English Aron R. Buy$2.63K
Dec 14, 2021English Aron R. Buy$2.43K
Dec 03, 2021English Aron R. Buy$26.68K
Dec 02, 2021English Aron R. Buy$73.33K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q3--

ANEB Ownership FAQ


Who Owns Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals shareholders are primarily institutional investors at 0.91%, followed by 40.54% insiders and 58.55% retail investors. The average institutional ownership in Anebulo Pharmaceuticals's industry, Biotech Stocks , is 45.22%, which Anebulo Pharmaceuticals falls below.

Who owns the most shares of Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals’s largest shareholders are 22nw, lp (15.47M shares, 45.73%), Nantahala capital management (3.04M shares, 8.98%), and Mangrove partners (2.53M shares, 7.47%). Together, they hold 62.18% of Anebulo Pharmaceuticals’s total shares outstanding.

Does Blackrock own Anebulo Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Anebulo Pharmaceuticals.

Who is Anebulo Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

22nw, lp is Anebulo Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 18.22% of its assets in 15.47M Anebulo Pharmaceuticals shares, valued at 38.67M$.

Who is the top mutual fund holder of Anebulo Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Anebulo Pharmaceuticals shares, with 0.29% of its total shares outstanding invested in 121K Anebulo Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools